ReFacto AF® – Live life more freely

ReFacto AF (moroctocog alfa – recombinant coagulation factor VIII) is indicated for the treatment and prophylaxis of bleeding in patients with Haemophilia A (congenital factor VIII deficiency).

ReFacto AF prescribing information is available here.

PP-REF-GBR-0154. October 2018